Intra-Cellular Therapies, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Intra-Cellular Therapies, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2012 to Q4 2023.
  • Intra-Cellular Therapies, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $271M, a 22.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $271M +$50.3M +22.8% Dec 31, 2023 10-K 2024-02-22
Q4 2022 $220M +$53.7M +32.3% Dec 31, 2022 10-K 2024-02-22
Q4 2021 $167M +$53.3M +47% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $113M +$40M +54.5% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $73.3M +$8.31M +12.8% Dec 31, 2019 10-K 2021-02-25
Q4 2018 $65M +$5.01M +8.35% Dec 31, 2018 10-K 2020-03-02
Q4 2017 $60M -$11M -15.5% Dec 31, 2017 10-K 2019-02-27
Q4 2016 $71M -$19.6M -21.6% Dec 31, 2016 10-K 2018-03-01
Q4 2015 $90.6M +$51.2M +130% Dec 31, 2015 10-K 2017-03-01
Q4 2014 $39.4M +$14.7M +59.1% Dec 31, 2014 10-K 2016-02-25
Q4 2013 $24.8M +$13.2M +114% Dec 31, 2013 10-K 2015-03-12
Q4 2012 $11.6M Dec 31, 2012 10-K 2014-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.